Credit Suisse’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-89,490
| Closed | -$376K | – | 3316 |
|
2023
Q1 | $376K | Buy |
89,490
+15,357
| +21% | +$64.5K | ﹤0.01% | 2887 |
|
2022
Q4 | $446K | Buy |
74,133
+73,561
| +12,860% | +$442K | ﹤0.01% | 2843 |
|
2022
Q3 | $3K | Buy |
572
+526
| +1,143% | +$2.76K | ﹤0.01% | 3668 |
|
2022
Q2 | $0 | Buy |
+46
| New | – | ﹤0.01% | 4601 |
|
2021
Q2 | – | Sell |
-14,117
| Closed | -$41K | – | 3790 |
|
2021
Q1 | $41K | Buy |
+14,117
| New | +$41K | ﹤0.01% | 3377 |
|
2019
Q3 | – | Sell |
-12,549
| Closed | -$11K | – | 3584 |
|
2019
Q2 | $11K | Sell |
12,549
-13,761
| -52% | -$12.1K | ﹤0.01% | 3411 |
|
2019
Q1 | $26K | Buy |
+26,310
| New | +$26K | ﹤0.01% | 3343 |
|
2018
Q3 | – | Sell |
-22,233
| Closed | -$110K | – | 3571 |
|
2018
Q2 | $110K | Buy |
22,233
+11,143
| +100% | +$55.1K | ﹤0.01% | 3365 |
|
2018
Q1 | $43K | Buy |
+11,090
| New | +$43K | ﹤0.01% | 3462 |
|
2016
Q4 | – | Sell |
-4,419
| Closed | -$16K | – | 3911 |
|
2016
Q3 | $16K | Sell |
4,419
-41,960
| -90% | -$152K | ﹤0.01% | 3715 |
|
2016
Q2 | $158K | Buy |
46,379
+24,509
| +112% | +$83.5K | ﹤0.01% | 3643 |
|
2016
Q1 | $117K | Buy |
21,870
+10,179
| +87% | +$54.5K | ﹤0.01% | 3504 |
|
2015
Q4 | $144K | Buy |
11,691
+1,874
| +19% | +$23.1K | ﹤0.01% | 3777 |
|
2015
Q3 | $143K | Sell |
9,817
-1,794
| -15% | -$26.1K | ﹤0.01% | 3821 |
|
2015
Q2 | $226K | Buy |
11,611
+2,633
| +29% | +$51.3K | ﹤0.01% | 3872 |
|
2015
Q1 | $163K | Sell |
8,978
-1,016
| -10% | -$18.4K | ﹤0.01% | 3855 |
|
2014
Q4 | $236K | Buy |
9,994
+2,300
| +30% | +$54.3K | ﹤0.01% | 3825 |
|
2014
Q3 | $186K | Sell |
7,694
-9,707
| -56% | -$235K | ﹤0.01% | 3768 |
|
2014
Q2 | $489K | Sell |
17,401
-81
| -0.5% | -$2.28K | ﹤0.01% | 3420 |
|
2014
Q1 | $594K | Sell |
17,482
-29,603
| -63% | -$1.01M | ﹤0.01% | 3219 |
|
2013
Q4 | $899K | Buy |
47,085
+1,418
| +3% | +$27.1K | ﹤0.01% | 2964 |
|
2013
Q3 | $740K | Buy |
45,667
+32,328
| +242% | +$524K | ﹤0.01% | 2796 |
|
2013
Q2 | $140K | Buy |
+13,339
| New | +$140K | ﹤0.01% | 3551 |
|